Landau SM - Search Results

1

Tracking the earliest pathologic changes in Alzheimer disease.

Landau SM, Frosch MP. Landau SM, et al. Neurology. 2014 May 6;82(18):1576-7. doi: 10.1212/WNL.0000000000000392. Epub 2014 Apr 4. Neurology. 2014. PMID: 24706009

2

Associations between cognitive, functional, and FDG-PET measures of decline in AD and MCI.

Landau SM, Harvey D, Madison CM, Koeppe RA, Reiman EM, Foster NL, Weiner MW, Jagust WJ; Alzheimer's Disease Neuroimaging Initiative. Landau SM, et al. Neurobiol Aging. 2011 Jul;32(7):1207-18. doi: 10.1016/j.neurobiolaging.2009.07.002. Epub 2009 Aug 5. Neurobiol Aging. 2011. PMID: 19660834 Free PMC article. Clinical Trial.

3

Relationships between biomarkers in aging and dementia.

Jagust WJ, Landau SM, Shaw LM, Trojanowski JQ, Koeppe RA, Reiman EM, Foster NL, Petersen RC, Weiner MW, Price JC, Mathis CA; Alzheimer's Disease Neuroimaging Initiative. Jagust WJ, et al. Among authors: landau sm. Neurology. 2009 Oct 13;73(15):1193-9. doi: 10.1212/WNL.0b013e3181bc010c. Neurology. 2009. PMID: 19822868 Free PMC article.

4

The Alzheimer's Disease Neuroimaging Initiative positron emission tomography core.

Jagust WJ, Bandy D, Chen K, Foster NL, Landau SM, Mathis CA, Price JC, Reiman EM, Skovronsky D, Koeppe RA; Alzheimer's Disease Neuroimaging Initiative. Jagust WJ, et al. Among authors: landau sm. Alzheimers Dement. 2010 May;6(3):221-9. doi: 10.1016/j.jalz.2010.03.003. Alzheimers Dement. 2010. PMID: 20451870 Free PMC article.

5

Comparing predictors of conversion and decline in mild cognitive impairment.

Landau SM, Harvey D, Madison CM, Reiman EM, Foster NL, Aisen PS, Petersen RC, Shaw LM, Trojanowski JQ, Jack CR Jr, Weiner MW, Jagust WJ; Alzheimer's Disease Neuroimaging Initiative. Landau SM, et al. Neurology. 2010 Jul 20;75(3):230-8. doi: 10.1212/WNL.0b013e3181e8e8b8. Epub 2010 Jun 30. Neurology. 2010. PMID: 20592257 Free PMC article.

6

Characterizing Alzheimer's disease using a hypometabolic convergence index.

Chen K, Ayutyanont N, Langbaum JB, Fleisher AS, Reschke C, Lee W, Liu X, Bandy D, Alexander GE, Thompson PM, Shaw L, Trojanowski JQ, Jack CR Jr, Landau SM, Foster NL, Harvey DJ, Weiner MW, Koeppe RA, Jagust WJ, Reiman EM; Alzheimer's Disease Neuroimaging Initiative. Chen K, et al. Among authors: landau sm. Neuroimage. 2011 May 1;56(1):52-60. doi: 10.1016/j.neuroimage.2011.01.049. Epub 2011 Jan 27. Neuroimage. 2011. PMID: 21276856 Free PMC article.

7

Association of lifetime cognitive engagement and low β-amyloid deposition.

Landau SM, Marks SM, Mormino EC, Rabinovici GD, Oh H, O'Neil JP, Wilson RS, Jagust WJ. Landau SM, et al. Arch Neurol. 2012 May;69(5):623-29. doi: 10.1001/archneurol.2011.2748. Arch Neurol. 2012. PMID: 22271235 Free PMC article.

8

Amyloid deposition, hypometabolism, and longitudinal cognitive decline.

Landau SM, Mintun MA, Joshi AD, Koeppe RA, Petersen RC, Aisen PS, Weiner MW, Jagust WJ; Alzheimer's Disease Neuroimaging Initiative. Landau SM, et al. Ann Neurol. 2012 Oct;72(4):578-86. doi: 10.1002/ana.23650. Ann Neurol. 2012. PMID: 23109153 Free PMC article.

9

Amyloid-β imaging with Pittsburgh compound B and florbetapir: comparing radiotracers and quantification methods.

Landau SM, Breault C, Joshi AD, Pontecorvo M, Mathis CA, Jagust WJ, Mintun MA; Alzheimer’s Disease Neuroimaging Initiative. Landau SM, et al. J Nucl Med. 2013 Jan;54(1):70-7. doi: 10.2967/jnumed.112.109009. Epub 2012 Nov 19. J Nucl Med. 2013. PMID: 23166389 Free PMC article.

10

Apolipoprotein E, not fibrillar β-amyloid, reduces cerebral glucose metabolism in normal aging.

Jagust WJ, Landau SM; Alzheimer's Disease Neuroimaging Initiative. Jagust WJ, et al. Among authors: landau sm. J Neurosci. 2012 Dec 12;32(50):18227-33. doi: 10.1523/JNEUROSCI.3266-12.2012. J Neurosci. 2012. PMID: 23238736 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results